Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance
暂无分享,去创建一个
J. Shao | F. Wang | Sha Fu | H. Long | X. Su | Zerui Zhao | Yong-bin Lin | Long Jiang | Jinfeng Wang | Shulian Zhang | Yigong Zhang | Ze-Rui Zhao | Xiaodong Su